Tony Butler
Stock Analyst at Rodman & Renshaw
(0.57)
# 4,155
Out of 5,154 analysts
88
Total ratings
27.38%
Success rate
-22.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $5.17 | +383.56% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $1.50 | +633.33% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.39 | +1,194.96% | 4 | Sep 26, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $2.56 | +525.00% | 5 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.33 | +651.88% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $56.50 | +32.74% | 8 | Aug 8, 2023 | |
| GTBP GT Biopharma | Reiterates: Hold | $60 | $0.47 | +12,685.00% | 5 | Aug 7, 2023 | |
| CGEN Compugen | Reiterates: Buy | $13 | $2.08 | +525.00% | 6 | Aug 7, 2023 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $50 | $5.20 | +861.54% | 5 | Aug 3, 2023 | |
| ALLO Allogene Therapeutics | Reiterates: Buy | $15 | $2.30 | +552.17% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.17 | +14,798.69% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.37 | +994.89% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $3.94 | +153.81% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $0.73 | +2,238.38% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $2.96 | +5,508.11% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $8.07 | +643.49% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $1.72 | +13,853.49% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.20 | +2,928.77% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $0.62 | +57,955.15% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $2.80 | -28.57% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $0.86 | +1,643.98% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $1.38 | +624.64% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $5.51 | +172.23% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $13.44 | +718.45% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $960 | $12.07 | +7,853.60% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $5.17
Upside: +383.56%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $1.50
Upside: +633.33%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.39
Upside: +1,194.96%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $2.56
Upside: +525.00%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.33
Upside: +651.88%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $56.50
Upside: +32.74%
GT Biopharma
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $0.47
Upside: +12,685.00%
Compugen
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $2.08
Upside: +525.00%
Bicycle Therapeutics
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $5.20
Upside: +861.54%
Allogene Therapeutics
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $2.30
Upside: +552.17%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.17
Upside: +14,798.69%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.37
Upside: +994.89%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $3.94
Upside: +153.81%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $0.73
Upside: +2,238.38%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $2.96
Upside: +5,508.11%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $8.07
Upside: +643.49%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $1.72
Upside: +13,853.49%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.20
Upside: +2,928.77%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $0.62
Upside: +57,955.15%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $2.80
Upside: -28.57%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $0.86
Upside: +1,643.98%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $1.38
Upside: +624.64%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $5.51
Upside: +172.23%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $13.44
Upside: +718.45%
Mar 2, 2020
Initiates: Buy
Price Target: $960
Current: $12.07
Upside: +7,853.60%